Basal Glucose on Tolerance Test During Pregnancy Predicts Impaired Fasting Glucose and Type 2 Diabetes Within 2 Months After Gestational Diabetes

被引:2
|
作者
Olmos, Pablo [1 ,2 ,3 ]
Borzone, Gisella [4 ]
Poblete, Andres [1 ]
机构
[1] Pontificia Univ Catolica Chile, Coll Med, Dept Obstet & Gynecol, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Coll Med, Dept Nutr Diabet & Metab, Ave Libertador Bernardo OHiggins 340, Santiago 6513492, Chile
[3] Pontificia Univ Catolica Chile, Coll Med, Ctr Biomed Engn 1, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Coll Med, Dept Resp Dis, Santiago, Chile
关键词
diabetes; gestational; glucose; impaired; postpartum; tolerance; INSULIN SENSITIVITY; WOMEN; MELLITUS; SECRETION; CURVE; RATES; RISK;
D O I
10.1016/j.jcjd.2020.06.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Postpartum mothers with gestational diabetes may remain with either type 2 diabetes mellitus, impaired glucose tolerance or impaired fasting glucose. Our aim in this study was to identify maternal variables that could predict 1 or more of these conditions. Methods: In 193 singleton pregnancies with gestational diabetes, we applied bivariate logistic regression and receiver-operating characteristic curves to data from the index glucose-challenge test that allowed the diagnosis of gestational diabetes. Results: Receiver-operating characteristic curves of fasting glucose from the index glucose-challenge test predicted impaired fasting glucose and type 2 diabetes mellitus combined, with a sensitivity of 100%, false-positive rate of 40.5%, area under the curve of 0.849, p=0.004 and positive predictive value 45%, and with a cutoff point of 4.7 mmol/L. Conclusions: At the time of diagnosis of gestational diabetes during pregnancy, a basal glucose level of >= 4.7 mmol/L on index glucose-challenge test indicates a 45% probability of either type 2 diabetes mellitus or impending diabetes early postpartum. (C) 2020 Canadian Diabetes Association.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [41] Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type 2 Diabetes
    Jiang, Yanqiu
    Cui, Shiwei
    Zhang, Rongping
    Zhao, Xiaoqin
    Yao, Lili
    OuYang, Rong
    Chen, Wei
    Zhou, Ranran
    Zhao, Xuying
    Tang, Zhuqi
    Yuan, Jin
    Yuan, Jie
    Qian, Chen
    Huang, Ping
    Gu, Yunjuan
    Wang, Xinlei
    DIABETES THERAPY, 2021, 12 (09) : 2437 - 2450
  • [42] Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
    Pixner, Thomas
    Chaikouskaya, Tatsiana
    Lauth, Wanda
    Zimmermann, Georg
    Moerwald, Katharina
    Lischka, Julia
    Furthner, Dieter
    Awender, Elisabeth
    Geiersberger, Sabine
    Maruszczak, Katharina
    Forslund, Anders
    Anderwald, Christian-Heinz
    Cadamuro, Janne
    Weghuber, Daniel
    Bergsten, Peter
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [43] Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes
    Tankova, Tsvetalina
    Chakarova, Nevena
    Atanassova, Iliana
    Dakovska, Lilia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (01) : 46 - 52
  • [44] Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients
    Gianotti, N.
    Visco, F.
    Galli, L.
    Barda, B.
    Piatti, P.
    Salpietro, S.
    Bigoloni, A.
    Vinci, C.
    Nozza, S.
    Gallotta, G.
    Lazzarin, A.
    Castagna, A.
    HIV MEDICINE, 2011, 12 (02) : 109 - 117
  • [45] A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project
    Leite, Silmara A. O.
    Anderson, Robyn L.
    Kendall, David M.
    Monk, Arlene M.
    Bergenstal, Richard M.
    DIABETOLOGY & METABOLIC SYNDROME, 2009, 1
  • [46] A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T. C.
    Schwartz, S.
    Rosenberg, M. A.
    Jarlwala, N.
    Becker, R. H. A.
    Johnston, P. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (05) : 282 - 288
  • [47] Antenatal oral glucose tolerance test in women with gestational diabetes mellitus: fasting plasma glucose is the best predictor of both large for-gestational-age newborns and postpartum glucose tolerance
    Monroy, Gabriela
    Tundidor, Diana
    Orellana, Inmaculada
    Garcia-Patterson, Apolonia
    Adelantado, Juan M.
    Corcoy, Rosa
    MINERVA ENDOCRINOLOGICA, 2017, 42 (04) : 311 - 317
  • [48] Fasting plasma glucose as a screening test for gestational diabetes mellitus
    Agarwal M.M.
    Dhatt G.S.
    Archives of Gynecology and Obstetrics, 2007, 275 (2) : 81 - 87
  • [49] Delay in glucose peak time during the oral glucose tolerance test as an indicator of insulin resistance and insulin secretion in type 2 diabetes patients
    Wang, Xinlei
    Zhao, Xiaoqin
    Zhou, Ranran
    Gu, Yunjuan
    Zhu, Xiaohui
    Tang, Zhuqi
    Yuan, Xinlu
    Chen, Wei
    Zhang, Rongping
    Qian, Chen
    Cui, Shiwei
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (06) : 1288 - 1295
  • [50] One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose
    Fiorentino, Teresa Vanessa
    Marini, Maria Adelaide
    Andreozzi, Francesco
    Arturi, Franco
    Succurro, Elena
    Perticone, Maria
    Sciacqua, Angela
    Hribal, Marta Letizia
    Perticone, Francesco
    Sesti, Giorgio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10) : 3744 - 3751